Chestnut Health Systems, 221 W. Walton St., Chicago, IL 60610, USA..
Carnevale Associates LLC, 4 Belinder Rd., Gaithersburg, MD 20878, USA..
J Subst Abuse Treat. 2022 Jul;138:108718. doi: 10.1016/j.jsat.2021.108718. Epub 2022 Jan 4.
Individuals with substance use disorders (SUD) must be linked to community-based SUD treatment and other services upon their release from jail, given their high service needs and risks for relapse, recidivism, and opioid-related overdose following release.
This scoping review identified 14 studies (28 affiliated publications) that used experimental or quasi-experimental designs to evaluate jail re-entry interventions for individuals with SUD. The team coded intervention components, study characteristics, and study outcomes based on a service continuum for treatment linkage and retention and for post-release substance use and criminal justice outcomes.
This review included 4 randomized controlled trials (RCT) for linkage to treatment with medications for opioid use disorder (MOUD); 4 RCTs and 4 quasi-experimental studies for linkage to non-specific SUD treatment; and 2 RCTs for linkage to HIV + SUD services. Most studies (9/14) used case management and/or peer or patient navigation as the core intervention; 2 studies provided medical management for MOUD induction and/or facilitated referral to MOUD in the community; and 3 studies used motivational-based linkage interventions. A qualitative analysis of study outcomes found evidence to support the effectiveness of a diverse range of interventions to link individuals to community-based SUD treatment, MOUD, and other services at re-entry, but limited support for intervention effects on longer-term outcomes, including treatment retention, medication adherence, recidivism, and substance use.
Future controlled trials and implementation studies should help to unpack and examine core components of jail re-entry interventions and their successful implementation to enhance treatment retention and improve post-release outcomes.
由于物质使用障碍(SUD)患者的服务需求高,且在出狱后复发、再犯罪和阿片类药物相关过量的风险较高,因此在他们出狱时必须将他们与社区为基础的 SUD 治疗和其他服务联系起来。
本范围综述确定了 14 项研究(28 项相关出版物),这些研究使用实验或准实验设计来评估针对 SUD 患者的监狱重新进入干预措施。该团队根据治疗联系和保留以及出狱后的物质使用和刑事司法结果的服务连续体,对干预措施组成部分、研究特征和研究结果进行了编码。
本综述包括 4 项随机对照试验(RCT),用于将药物治疗与阿片类药物使用障碍(MOUD)联系起来;4 项 RCT 和 4 项准实验研究,用于将非特定 SUD 治疗联系起来;以及 2 项 RCT 用于将 HIV+SUD 服务联系起来。大多数研究(9/14)使用案例管理和/或同伴或患者导航作为核心干预措施;2 项研究提供了 MOUD 诱导的医疗管理,并/或促进了在社区中接受 MOUD 的转介;以及 3 项研究使用了基于动机的联系干预措施。对研究结果的定性分析表明,有证据支持将个人与社区为基础的 SUD 治疗、MOUD 和其他服务联系起来的各种干预措施的有效性,但对干预措施对长期结果(包括治疗保留、药物依从性、再犯罪和物质使用)的影响支持有限。
未来的对照试验和实施研究应有助于阐明和检查监狱重新进入干预措施的核心组成部分及其成功实施,以提高治疗保留率并改善出狱后的结果。